161 related articles for article (PubMed ID: 9293264)
1. A high incidence of melanoma found in patients with multiple dysplastic naevi by photographic surveillance.
Kelly JW; Yeatman JM; Regalia C; Mason G; Henham AP
Med J Aust; 1997 Aug; 167(4):191-4. PubMed ID: 9293264
[TBL] [Abstract][Full Text] [Related]
2. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population.
Augustsson A; Stierner U; Rosdahl I; Suurküla M
Acta Derm Venereol; 1991; 71(6):518-24. PubMed ID: 1685835
[TBL] [Abstract][Full Text] [Related]
3. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
[TBL] [Abstract][Full Text] [Related]
4. Melanomas detected with the aid of total cutaneous photography.
Feit NE; Dusza SW; Marghoob AA
Br J Dermatol; 2004 Apr; 150(4):706-14. PubMed ID: 15099367
[TBL] [Abstract][Full Text] [Related]
5. Melanoma risk in congenital melanocytic naevi: a systematic review.
Krengel S; Hauschild A; Schäfer T
Br J Dermatol; 2006 Jul; 155(1):1-8. PubMed ID: 16792745
[TBL] [Abstract][Full Text] [Related]
6. Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi.
Fleming NH; Egbert BM; Kim J; Swetter SM
JAMA Dermatol; 2016 Dec; 152(12):1327-1334. PubMed ID: 27542070
[TBL] [Abstract][Full Text] [Related]
7. Efficiency of Detecting New Primary Melanoma Among Individuals Treated in a High-risk Clinic for Skin Surveillance.
Guitera P; Menzies SW; Coates E; Azzi A; Fernandez-Penas P; Lilleyman A; Badcock C; Schmid H; Watts CG; Collgros H; Liu R; van Kemenade C; Mann GJ; Cust AE
JAMA Dermatol; 2021 May; 157(5):521-530. PubMed ID: 33729464
[TBL] [Abstract][Full Text] [Related]
8. Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.
Hussein MR
J Clin Pathol; 2005 May; 58(5):453-6. PubMed ID: 15858113
[TBL] [Abstract][Full Text] [Related]
9. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management.
Slade J; Marghoob AA; Salopek TG; Rigel DS; Kopf AW; Bart RS
J Am Acad Dermatol; 1995 Mar; 32(3):479-94. PubMed ID: 7868720
[TBL] [Abstract][Full Text] [Related]
10. Skin surveillance of a U.K. paediatric transplant population.
Thomson MA; Suggett NR; Nightingale PG; Milford DV; Baumann U; Kelly DA; Moss C; Hill VA
Br J Dermatol; 2007 Jan; 156(1):45-50. PubMed ID: 17199565
[TBL] [Abstract][Full Text] [Related]
11. Melanoma diagnosis during periodic surveillance of patients with multiple atypical naevi.
Rauwerdink DJW; Roach REJ; Etty MA; Kukutsch NA; van Doorn R
Br J Dermatol; 2018 Oct; 179(4):997-998. PubMed ID: 29704460
[No Abstract] [Full Text] [Related]
12. Multiple primary melanomas.
Stam-Posthuma JJ; van Duinen C; Scheffer E; Vink J; Bergman W
J Am Acad Dermatol; 2001 Jan; 44(1):22-7. PubMed ID: 11148472
[TBL] [Abstract][Full Text] [Related]
13. [Family studies on the incidence of multiple pigmented naevi, familial skin melanoma and other malignant tumors].
Szekeres L; Korom I
Orv Hetil; 1991 Sep; 132(39):2153-6. PubMed ID: 1923488
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy.
Bauer J; Blum A; Strohhäcker U; Garbe C
Br J Dermatol; 2005 Jan; 152(1):87-92. PubMed ID: 15656806
[TBL] [Abstract][Full Text] [Related]
15. Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndrome.
Tiersten AD; Grin CM; Kopf AW; Gottlieb GJ; Bart RS; Rigel DS; Friedman RJ; Levenstein MJ
J Dermatol Surg Oncol; 1991 Jan; 17(1):44-8. PubMed ID: 1991880
[TBL] [Abstract][Full Text] [Related]
16. Congenital melanocytic naevi and cutaneous melanoma.
Berg P; Lindelöf B
Melanoma Res; 2003 Oct; 13(5):441-5. PubMed ID: 14512785
[TBL] [Abstract][Full Text] [Related]
17. A prospective observational study of pigmented naevi changes in psoriasis patients on biologic therapy.
Choi SD; D'Souza MI; Menzies SW; Weninger W
Australas J Dermatol; 2019 Feb; 60(1):e14-e19. PubMed ID: 29797312
[TBL] [Abstract][Full Text] [Related]
18. [Melanocytic nevi as one of the risk factors of melanoma malignum].
Małaczewska J; Dabkowski J
Pol Merkur Lekarski; 2004 Mar; 16(93):298-302. PubMed ID: 15190614
[TBL] [Abstract][Full Text] [Related]
19. Prediction of histologic melanocytic dysplasia from clinical observation.
Roush GC; Dubin N; Barnhill RL
J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
[TBL] [Abstract][Full Text] [Related]
20. Lentinginous dysplastic naevi in the elderly: a potential precursor for malignant melanoma.
Kossard S; Commens C; Symons M; Doyle J
Australas J Dermatol; 1991; 32(1):27-37. PubMed ID: 1930003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
